雷洛昔芬属于哪种抗骨质疏松药物？雷洛昔芬可用于老年骨质疏松吗？

Raloxifene (Bebon) is called a "selective estrogen receptor modulator" by the medical community. In layman's terms, the so-called "selective estrogen receptor modulator" means that it has a stimulating effect on the estrogen receptors of some tissues or organs, while it has an inhibitory effect on the estrogen receptors of other tissues or organs (such as the breast and uterus). Which type of anti-osteoporosis drug does naraloxifene (Bebon) belong to? Can it be used for osteoporosis in the elderly?

Raloxifene (Bebon) indications

Raloxifene (Bebon) is mainly used to prevent and treat osteoporosis in postmenopausal women. Raloxifene (Bebon) can significantly reduce the incidence of vertebral fractures, but the reduction in the incidence of hip fractures has not been confirmed. If elderly patients with osteoporosis want to use raloxifene (Bebon) for treatment, they should first go to the hospital for a detailed examination and strictly follow the doctor's diagnosis and treatment recommendations.

Related clinical trials

The MORE trial selected 7705 postmenopausal women with osteoporosis and followed them for 48 months. After taking raloxifene (Bebon) for 1 year, the risk of vertebral fractures dropped by 68%; after taking raloxifene (Bebon) for 4 years, the risk of vertebral fractures dropped by 50%. According to the MORE study, the relative risk of breast cancer in raloxifene (Bebon) users was 70% lower than that in the control group. According to clinical trial data, the therapeutic effect of raloxifene (Bebon) is very significant.

Precautions for Raloxifene (Bebon)

Raloxifene (Bebon) is not suitable for male patients. The effects of raloxifene (Bebon) on the ability to drive and operate machines are unknown.

Raloxifene does not cause endometrial hyperplasia. Any uterine bleeding during treatment with raloxifene (Bebon) is unexpected and should be thoroughly examined by a specialist.

The above is the introduction about Raloxifene (Bebon). If patients want to know more about the drug information of Raloxifene (Bebon), they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: